We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It... Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. Show more
PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines...
PRINCETON, N.J., March 01, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.39 | -3.69318181818 | 10.56 | 10.93 | 10.02 | 3229267 | 10.66380369 | CS |
4 | -1.7 | -14.3218197136 | 11.87 | 11.93 | 10.02 | 2714738 | 11.06369166 | CS |
12 | -2.35 | -18.7699680511 | 12.52 | 14.03 | 10.02 | 3104504 | 12.22293105 | CS |
26 | -0.73 | -6.69724770642 | 10.9 | 14.57 | 9.7 | 3055773 | 12.17041957 | CS |
52 | -1.28 | -11.1790393013 | 11.45 | 14.57 | 9.7 | 2781034 | 12.23581631 | CS |
156 | 0.12 | 1.19402985075 | 10.05 | 14.57 | 5.91 | 2697639 | 10.92782685 | CS |
260 | -2.92 | -22.30710466 | 13.09 | 25.39 | 5.91 | 2728503 | 11.60637655 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions